Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

How Worrisome Is Ocugen's Latest Bad News?

TheMotleyFool

0 0

How Worrisome Is Ocugen's Latest Bad News?Photo, wide shot, wide-angle lens, Cleaning service, Midday, harsh overhead sunlight, directional sunlightt, photo by Marc Adamus: https://img.theapi.app/temp/66ee0081-ae60-418d-bd6e-b521f7433841.png

Ocugen (NASDAQ: OCGN) had hoped to move forward quickly with a U.S. late-stage clinical study of its COVID-19 vaccine candidate, Covaxin. However, those plans hit a speed bump when the Food and Drug Administration (FDA) placed a clinical hold on the study. In this Motley Fool Live video recorded on Dec. 1, 2021, Motley Fool contributors Keith Speights and Brian Orelli discuss how worrisome this news might be for Ocugen.

Source Fool.com

Like: 0

OCGN

Teilen